News in Brief

AudioCure Pharma enters clinical development phase with lead molecule AC102

AudioCure Pharma GmbH, a pharmaceutical company based in Berlin, Germany, announced today that the first healthy volunteers have been included into the Phase I trial with the first-in-class molecule AC102. Main primary endpoints of the open-label study are safety and tolerability of AC102-suspension after injection into the middle ear.

The AudioCure Family Grows Further

AudioCure has made exciting progress in its preclinical program by extending both its indication and compound pipelines in recent months. We are very pleased to announce that we have therefore extended our scientific team to continue pushing our preclinical...

The AudioCure Family is Growing

We are very happy to announce that we have expanded our team with further experts for formal preclinical and clinical development to propel our way into the clinical stage …

Relaunch of the AudioCure Website

It is with great pleasure that we announce the relaunch of our corporate brand and website. The brand design has been refined and updated to reflect AudioCure’s innovative and forward-thinking outlook. Meanwhile, we hope that with its clear structure, easy navigation...

AudioCure completes financing round with MED-EL and HTGF

AudioCure Pharma GmbH secures funding of about EUR 9 Million for the further development of their lead candidate, AC102, in hearing loss. Austrian company MED-EL Elektromedizinische Geräte GmbH (MED-EL), Innsbruck, the technology leader in implantable hearing...

AudioCure Pharma cooperates with Charité Universitätsmedizin, Berlin

We are very pleased to announce the start of our collaboration with Dr. Julian Hellmann-Regen, Head of the Clinical Neurobiology Laboratory at the Charité Universitätsmedizin, Berlin. Dr. Hellmann and his team will further investigate the molecular mode of action of...

Dr. Reimar Schlingensiepen has joined AudioCure

We are happy to announce that Dr. Reimar Schlingensiepen has joined AudioCure as COO. Dr. Schlingensiepen is an experienced entrepreneur and manager for biotech, medtech and diagnostics companies. He offers his leadership expertise in the multiple fields of the...